| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.24 | 0.6 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.23 | 0.2 |